Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Josep M Grinyo

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Saudi Journal of Kidney Diseases and Transplantation : an Official Publication of the Saudi Center for Organ Transplantation, Saudi Arabia|February 25, 2009
Transplantation: new protocols and new worriesJosep M Grinyo
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 14, 2006
Graft dysfunction and cardiovascular risk--an un-holy allianceFrancesc Moreso, Josep M Grinyo
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 9, 2011
Clinical assessment and determinants of chronic allograft nephropathy in maintenance renal transplant patientsJosep M Grinyo, Nuria Saval, Josep M Campistol, et al.
The New England Journal of Medicine|March 20, 2004
Chronic allograft nephropathyJuan Torras, Immaculada Herrero-Fresneda, Josep M Grinyo
Contributions to Nephrology|April 9, 2008
Gene therapy for acute renal failureJuan Torras, Josep M Cruzado, Immaculada Herrero-Fresneda, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|February 13, 2007
Ischemic preconditioning in solid organ transplantation: from experimental to clinicsJoan Torras Ambros, Immaculada Herrero-Fresneda, Oscar Gulias Borau, et al.
Transplantation|December 20, 2002
Improved renal function in sirolimus-treated renal transplant patients after early cyclosporine eliminationThomas A Gonwa, Donald E Hricik, Karl Brinker, et al.
Current Pharmaceutical Design|August 12, 2016
RNAi-Based Therapy in Experimental Ischemia-Reperfusion Injury. The New TargetsLaura de Ramon, Marta Jarque, Elia Ripoll, et al.
Atherosclerosis|November 12, 2016
Silencing of CD40 in vivo reduces progression of experimental atherogenesis through an NF-κB/miR-125b axis and reveals new potential mediators in the pathogenesis of atherosclerosisMiguel Hueso, Laura De Ramon, Estanislao Navarro, et al.
Data in Brief|December 8, 2016
Datasets for the validation of the "in vivo" siRNA-silencing of <i>CD40</i> and for the detection of new markers of atherosclerosis progression in ApoE-deficient miceMiguel Hueso, Laura De Ramon, Estanislao Navarro, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Saudi Journal of Kidney Diseases and Transplantation : an Official Publication of the Saudi Center for Organ Transplantation, Saudi Arabia|February 25, 2009
Transplantation: new protocols and new worriesJosep M Grinyo
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 14, 2006
Graft dysfunction and cardiovascular risk--an un-holy allianceFrancesc Moreso, Josep M Grinyo
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 9, 2011
Clinical assessment and determinants of chronic allograft nephropathy in maintenance renal transplant patientsJosep M Grinyo, Nuria Saval, Josep M Campistol, et al.
The New England Journal of Medicine|March 20, 2004
Chronic allograft nephropathyJuan Torras, Immaculada Herrero-Fresneda, Josep M Grinyo
Contributions to Nephrology|April 9, 2008
Gene therapy for acute renal failureJuan Torras, Josep M Cruzado, Immaculada Herrero-Fresneda, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|February 13, 2007
Ischemic preconditioning in solid organ transplantation: from experimental to clinicsJoan Torras Ambros, Immaculada Herrero-Fresneda, Oscar Gulias Borau, et al.
Transplantation|December 20, 2002
Improved renal function in sirolimus-treated renal transplant patients after early cyclosporine eliminationThomas A Gonwa, Donald E Hricik, Karl Brinker, et al.
Current Pharmaceutical Design|August 12, 2016
RNAi-Based Therapy in Experimental Ischemia-Reperfusion Injury. The New TargetsLaura de Ramon, Marta Jarque, Elia Ripoll, et al.
Atherosclerosis|November 12, 2016
Silencing of CD40 in vivo reduces progression of experimental atherogenesis through an NF-κB/miR-125b axis and reveals new potential mediators in the pathogenesis of atherosclerosisMiguel Hueso, Laura De Ramon, Estanislao Navarro, et al.
Data in Brief|December 8, 2016
Datasets for the validation of the "in vivo" siRNA-silencing of <i>CD40</i> and for the detection of new markers of atherosclerosis progression in ApoE-deficient miceMiguel Hueso, Laura De Ramon, Estanislao Navarro, et al.
Pageof 2